HCWB is trading at $4.99, up 469.63% today after HCW Biologics regained Nasdaq bid-price compliance and implemented a 1-for-6 reverse stock split.

  • The Nasdaq Hearings Panel found the company compliant on June 29, resolving previous listing deficiencies.
  • Nasdaq now lists the 1-for-6 reverse stock split as effective June 30, 2026, which served as the primary catalyst for the sharp price increase.
  • While broader markets are showing some strength, the rally is primarily driven by these company-specific regulatory and structural developments.